Danbury based Mannkind expects to hire as many as 100 new employees in the coming months as it ramps up the manufacturing of Afrezza, an inhalable form of insulin approved Friday by the FDA.
via Danbury Newswire http://ift.tt/1meYmYx
via Danbury Newswire http://ift.tt/1meYmYx
No comments:
Post a Comment